Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for Montelukast Sodium (generic) from Rising Pharma Holdings, expanding access to montelukast prod…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Montelukast Sodium as an original generic application (ANDA 201515).
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis [Phase 3]
This Phase 3 trial evaluated the effect of ciclesonide HFA nasal aerosol on the hypothalamic-pituitary-adrenal axis in perennial allergic rh…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 clinical trial update from Teva investigating HPA axis safety in adults and adolescents with perennial allergic rhinitis, with resul…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion [NA]
The clinical trial evaluating oxymetazoline hydrochloride in combination with a nasal corticosteroid for perennial allergic and non-allergic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older [Phase 3]
This clinical trial update reports the completion and posting of Phase 3 results for a six-month study of once-daily ciclesonide HFA nasal a…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis [Phase 3]
Phase 3 trial results for a nasal spray to treat perennial allergic rhinitis in children have been completed and results posted. The sponsor…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older [Phase 3]
Phase 3 study evaluating safety and efficacy of once-daily ciclesonide HFA for perennial allergic rhinitis in individuals 12 years and older…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis [Phase 4]
A Phase 4 study comparing fluticasone furoate nasal spray with placebo for perennial allergic rhinitis; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of CITUS Dry Syrup in children with perennial allergic rhinitis has completed.
-
FDA approval · 2012-02-03FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
-
FDA approval · 2011-12-16FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the product labeli…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled trial of mometasone furoate nasal spray in children with perennial allergic rhinitis ha…
-
FDA approval · 2011-09-23FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for fexofenadine hydrochloride from Dr. Reddy's Laboratories Limited, enabling the generic produ…
-
FDA label_change · 2011-06-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC, likely affecting labeling and/or indications.
-
FDA approval · 2011-04-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of fluticasone furoate nasal spray for two wee…
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating nasal carbon dioxide (CO2) for nasal congestion in perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) [Phase 3]
Phase 3 trial comparing mometasone furoate nasal spray with fluticasone propionate nasal spray in perennial allergic rhinitis completed with…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539) [Phase 4]
Phase 4 pharmacokinetic study of loratadine in Japanese pediatric and adult patients with perennial allergic rhinitis; results were posted i…
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246) [Phase 3]
Phase 3 trial assessing montelukast for perennial allergic rhinitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-05-31Clinical Trial Update: Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
Pilot clinical trial update evaluating allergy immunotherapy for prevention of viral respiratory infections in individuals with allergic rhi…
-
FDA approval · 2010-03-17FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' original application for a generic fixed-dose combination of fexofenadine HCl and pseudoephedrine HCl…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy [Phase 4]
A Phase 4 trial update compares Cosalin monotherapy to a Cosalin-Xarlin combination for perennial allergic rhinitis; the current status is u…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Safety Study of Olopatadine Nasal Spray [Phase 3]
Phase 3 safety study of olopatadine nasal spray for perennial allergic rhinitis has completed, with results posted in 2010.